OpenURL Connection Search

Select item for more details and to access through your institution.

Tandem versus single haematopoietic stem cell transplant and BV maintenance in relapsed/refractory Hodgkin lymphoma: A matched cohort analysis from the LYSA.
Published in:
British Journal of Haematology, 2023, v. 202, n. 2, p. 379, doi. 10.1111/bjh.18859
By:
- Marouf, A.;
- Molinari, N.;
- Sibon, D.;
- Cottereau, A. S.;
- Kanoun, S.;
- Antoine, C.;
- Debureaux, P. E.;
- Cavalieri, D.;
- Fornecker, L. M.;
- Casasnovas, R. O.;
- Herbaux, C.;
- Amorim, S.;
- Rossi, C.;
- Bouscary, D.;
- Brice, P.;
- Ghesquieres, H.;
- Tamburini, J.;
- Deau, B.
Publication type:
Article
Enteropathy-Associated T-Cell Lymphoma: Improving Treatment Strategies.
Published in:
Digestive Diseases, 2015, v. 33, n. 2, p. 231, doi. 10.1159/000369542
By:
- Nijeboer, P.;
- Malamut, G.;
- Mulder, C.J.;
- Cerf-Bensussan, N.;
- Sibon, D.;
- Bouma, G.;
- Cellier, C.;
- Hermine, O.;
- Visser, O.
Publication type:
Article
Two Atypical Cases of Cutaneous Gamma/Delta T-Cell Lymphomas.
Published in:
Dermatology (10188665), 2011, v. 222, n. 4, p. 297, doi. 10.1159/000327932
By:
- Caudron, A.;
- Bouaziz, J.D.;
- Battistella, M.;
- Sibon, D.;
- Lok, C.;
- Leclech, C.;
- Ortonne, N.;
- Molinier-Frenkel, V.;
- Bagot, M.
Publication type:
Article
Treatment with anti CD19 CAR‐T cells is safe and effective in patients with relapsed refractory large B‐cell lymphoma with active central nervous system involvement.
Published in:
Hematological Oncology, 2023, v. 41, p. 456, doi. 10.1002/hon.3164_336
By:
- Marieton, E. Robin;
- Le Bras, F.;
- Malfuson, J.;
- Camus, V.;
- Legendre, H.;
- Degoutte, C.;
- Gounot, R.;
- Belhadj, K.;
- Sibon, D.;
- Dupuis, J.;
- Kamoun, G.;
- Hammoud, M.;
- El Gnaoui, T.;
- Poullot, E.;
- Ferchiou, A. Beldi;
- Claudel, A.;
- Menouche, D.;
- Mebarki, M.;
- Dejorna, R.;
- Melica, G.
Publication type:
Article
CHROMATIN ACCESSIBILITY PROFILING TO INCREASE DIAGNOSTIC ACCURACY AND REFINE CELL‐OF‐ORIGIN CLASSIFICATION OF MATURE T‐CELL LYMPHOMAS.
Published in:
Hematological Oncology, 2023, v. 41, p. 192, doi. 10.1002/hon.3163_123
By:
- Julia, E.;
- Mareschal, S.;
- Chebel, A.;
- Camille, G.;
- Missaglia, E.;
- Rattina, V.;
- Lours, C.;
- Testard, Q.;
- Tschantz, M.;
- Sebai, S.;
- Hadj‐Hamou, S.;
- Bissay, N.;
- Verney, A.;
- Chartoire, D.;
- Marçais, A.;
- Sibon, D.;
- Carras, S.;
- Salles, G.;
- Chassagne‐Clément, C.;
- Martin, L.
Publication type:
Article
LONG‐TERM OUTCOMES OF ELDERLY PATIENTS TREATED WITH FRONTLINE R‐CHOP: UPDATE OF THE LNH03‐6B TRIAL.
Published in:
Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.96_2880
By:
- Camus, V.;
- Belot, Aurél.;
- Oberic, L.;
- Sibon, D.;
- Ghesquières, H.;
- Thieblemont, C.;
- Fruchart, C.;
- Casasnovas, O.;
- Michot, Jean‐M.;
- Molina, T. J.;
- Bosly, A.;
- Joubert, Clém.;
- Haioun, C.;
- Delarue, R.;
- Tilly, H.
Publication type:
Article
EARLY POSITRON EMISSION TOMOGRAPHY RESPONSE‐ADAPTED TREATMENT IN LOCALIZED DIFFUSE LARGE B‐CELL LYMPHOMA (AAIPI=0) : RESULTS OF THE PHASE 3 LYSA LNH 09‐1B TRIAL.
Published in:
Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.5_2879
By:
- Bologna, S;
- Vander Borght, T;
- Briere, J;
- Ribrag, V;
- Damaj, G. L;
- Thieblemont, C;
- Feugier, P;
- Peyrade, F;
- Lebras, L;
- Coso, D;
- Sibon, D;
- Bonnet, C;
- Morschhauser, F;
- Ghesquieres, H;
- Becker, S;
- Olivier, P;
- Fabiani, B;
- Tilly, H;
- Haioun, C;
- Bastie, J. N
Publication type:
Article
ATEZOLIZUMAB + OBINUTUZUMAB + VENETOCLAX IN PATIENTS WITH RELAPSED OR REFRACTORY FOLLICULAR LYMPHOMA: PRIMARY ANALYSIS OF A PHASE 2 TRIAL FROM LYSA.
Published in:
Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.22_2880
By:
- Cartron, G.;
- Bachy, E.;
- Guidez, S.;
- Gyan, E.;
- Gressin, R.;
- Morineau, N.;
- Sibon, D.;
- Casasnovas, O.;
- Le Gouill, S.;
- Tilly, H.;
- Ysebaert, L.;
- Schiano de Colella, J. M.;
- Feugier, P.;
- Virelizier, E. Nicolas;
- Haioun, C.;
- Damaj, G.;
- Tarte, K.;
- Laurent, C.;
- Houot, R.;
- Thieblemont, C.
Publication type:
Article
GENDER DISPARITIES IN QUALITY OF LIFE OF FRENCH PATIENTS ONE YEAR AFTER THE DIAGNOSIS OF LYMPHOMA. A LYSA STUDY.
Published in:
Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.192_2880
By:
- Paunescu, A.‐C.;
- Paget, J.;
- Bergman, C. Copie;
- Malak, S.;
- Le Gouill, S.;
- Ribrag, V.;
- Bouabdallah, K.;
- Sibon, D.;
- Rumpold, G.;
- Preau, M.;
- Mounier, N.;
- Haioun, C.;
- Jardin, F.;
- Besson, C.
Publication type:
Article
IMPACT OF DUSP22 REARRANGEMENT ON THE PROGNOSIS OF SYSTEMIC ALK‐NEGATIVE ANAPLASTIC LARGE CELL LYMPHOMA: A LYSA AND TENOMIC STUDY.
Published in:
Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.137_2880
By:
- Sibon, D;
- Bisig, B;
- Bonnet, C;
- Bachy, E;
- Cavalieri, D;
- Fataccioli, V;
- Drieux, F;
- Bruneau, J;
- Lemonnier, F;
- Bossard, C;
- Bouabdallah, K;
- Parrens, M;
- Damaj, G;
- Tournilhac, O;
- Jais, J. P;
- Gaulard, P;
- de Leval, L
Publication type:
Article
AMAHRELIS : ADCETRIS MAINTENANCE AFTER AUTOLOGOUS STEM CELL TRANSPLANTATION IN HODGKIN LYMPHOMA : A REAL LIFE STUDY FROM SFGMTC AND LYSA GROUPS.
Published in:
Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.101_2880
By:
- Marouf, A.;
- Cottereau, A. S.;
- Kanoun, S.;
- Deschamps, P.;
- Franchi, P.;
- Meignan, M.;
- Sibon, D.;
- Gastinne, T.;
- Borel, C.;
- Hammoud, M.;
- Sicard, G.;
- Gille, R.;
- Cavalieri, D.;
- Stamatoullas, A.;
- Clement, L.;
- Lazarovici, J.;
- Chauchet, A.;
- Fornecker, L. M.;
- Amorin, S.;
- Rocquet, M.
Publication type:
Article
FIRST‐LINE THERAPY OF T‐CELL LYMPHOMA: ALLOGENEIC OR AUTOLOGOUS TRANSPLANTATION FOR CONSOLIDATION ‐ FINAL RESULTS OF THE AATT STUDY.
Published in:
Hematological Oncology, 2019, v. 37, p. 99, doi. 10.1002/hon.64_2629
By:
- Tournilhac, O.;
- Truemper, L.;
- Ziepert, M.;
- Bouabdallah, K.;
- Nickelsen, M.;
- Maury, S.;
- Reimer, P.;
- Jaccard, A.;
- Herr, W.;
- Wilhelm, M.;
- Cartron, G.;
- Wulf, G.;
- Sanhes, L.;
- Dreger, P.;
- Lamy, T.;
- Kroschinsky, F.;
- Lindemann, H.;
- Roussel, M.;
- Viardot, A.;
- Sibon, D.
Publication type:
Article
POOLED RESULTS OF THREE ANNUAL COHORTS FROM AN OBSERVATIONAL PROSPECTIVE STUDY DESCRIBING BRENTUXIMAB VEDOTIN USE IN ROUTINE PRACTICE IN FRANCE FOR HODGKIN LYMPHOMA: INTERIM ANALYSIS.
Published in:
Hematological Oncology, 2019, v. 37, p. 492, doi. 10.1002/hon.170_2631
By:
- Sibon, D.;
- Quittet, P.;
- Borel, C.;
- Stamatoullas, A.;
- Franchi‐Rezgui, P.;
- Ghesquieres, H.;
- Dulery, R.;
- Benbrahim, O.;
- Hammoud, M.;
- Durot, E.;
- De Guibert, S.;
- Coulibaly, C.;
- Casasnovas, O.;
- Bouabdallah, R.;
- Brice, P.
Publication type:
Article
FIRST‐LINE THERAPY OF T‐CELL LYMPHOMA: ALLOGENEIC OR AUTOLOGOUS TRANSPLANTATION FOR CONSOLIDATION ‐ FINAL RESULTS OF THE AATT STUDY.
Published in:
Hematological Oncology, 2019, v. 37, p. 99, doi. 10.1002/hon.64_2629
By:
- Tournilhac, O.;
- Truemper, L.;
- Ziepert, M.;
- Bouabdallah, K.;
- Nickelsen, M.;
- Maury, S.;
- Reimer, P.;
- Jaccard, A.;
- Herr, W.;
- Wilhelm, M.;
- Cartron, G.;
- Wulf, G.;
- Sanhes, L.;
- Dreger, P.;
- Lamy, T.;
- Kroschinsky, F.;
- Lindemann, H.;
- Roussel, M.;
- Viardot, A.;
- Sibon, D.
Publication type:
Article
POOLED RESULTS OF THREE ANNUAL COHORTS FROM AN OBSERVATIONAL PROSPECTIVE STUDY DESCRIBING BRENTUXIMAB VEDOTIN USE IN ROUTINE PRACTICE IN FRANCE FOR HODGKIN LYMPHOMA: INTERIM ANALYSIS.
Published in:
Hematological Oncology, 2019, v. 37, p. 492, doi. 10.1002/hon.170_2631
By:
- Sibon, D.;
- Quittet, P.;
- Borel, C.;
- Stamatoullas, A.;
- Franchi‐Rezgui, P.;
- Ghesquieres, H.;
- Dulery, R.;
- Benbrahim, O.;
- Hammoud, M.;
- Durot, E.;
- De Guibert, S.;
- Coulibaly, C.;
- Casasnovas, O.;
- Bouabdallah, R.;
- Brice, P.
Publication type:
Article
NKP46 EXPRESSION IS A DIAGNOSTIC AND PROGNOSTIC BIOMARKER IN PRIMARY GASTROINTESTINAL T-CELL LYMPHOPROLIFERATIONS. A CELAC NETWORK STUDY.
Published in:
Hematological Oncology, 2017, v. 35, p. 44, doi. 10.1002/hon.2437_26
By:
- Cheminant, M.;
- Bruneau, J.;
- Malamut, G.;
- Sibon, D.;
- Guegan, N.;
- Trinquand, A.;
- Lhermitte, L.;
- Brousse, N.;
- Suarez, F.;
- Frenzel, L.;
- Delarue, R.;
- Marçais, A.;
- Macintyre, E.;
- Asnafi, V.;
- Lhospice, F.;
- Bonnafous, C.;
- Molina, T.;
- Meresse, B.;
- Cellier, C.;
- Cerf ‐ Bensussan, N.
Publication type:
Article
PROGNOSTIC FACTORS AND IMPACT OF ETOPOSIDE IN ADULTS WITH SYSTEMIC ALK-POSITIVE ANAPLASTIC LARGE-CELL LYMPHOMA: A POOLED ANALYSIS OF SIX STUDIES.
Published in:
Hematological Oncology, 2017, v. 35, p. 240, doi. 10.1002/hon.2438_103
By:
- Sibon, D.;
- Nguyen, D.;
- Schmitz, N.;
- Suzuki, R.;
- Feldman, A.L.;
- Gressin, R.;
- Lamant, L.;
- Weisenburger, D.;
- Nakamura, S.;
- Ziepert, M.;
- Maurer, M.J.;
- Bast, M.;
- Armitage, J.O.;
- Vose, J.M.;
- Tilly, H.;
- Jais, J.P.;
- Savage, K.J.
Publication type:
Article

Found: 17